The Pensylvania-based company, which markets skin care products to dermatologists as well as developing laser treatments for the medical market, will finance the acquisition through a third party investment fund.
Developing light therapy for cosmetics
For PTL the union will provide the necessary investment to develop its LED light based therapy in the field of cosmetics.
“It makes perfect sense to team up with PhotoMedex. Working together, we can answer the demand in this emerging market,” said PTL’s CEO Sue D’Arcy.
The news follows shortly after the commercial release of PTL’s LED light therapy technology, through a partnership with skin care company N.V. Perricone Cosmeceuticals, and the now parent company PhotoMedex.
Perricone’s LIGHT Renewal treatment was launched last week onto the prestige beauty market.
Combining light with formulations
The treatment combined PTL’s Omnilux technology with Dr Perricone’s cleanser and serum formulations. According to the company, the products prepare the skin so that they are ready to receive the benefits provided by the light therapy.
Together, the products improve skin tone, texture and firmness and help to soften fine lines and wrinkles, the companies claim.
“We believe there is a dynamic synergy between our LED Light Therapy technology and Perricone MD Cosmeceuticals that will deliver exceptional results,” said D’Arcy.
The popularity of light-based therapies and their move into the home market is providing new opportunities for skin care manufacturers, which can develop products specifically targeting these treatment options.